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Abstract
High intakes of fruit and vegetables may reduce the risk of cancer at several sites. Evidence has been derived mainly from case–control
studies. We reviewed the relationship between consumption of vegetables and fruit and the risk of several common cancers in a network of
Italian and Swiss case–control studies including over 10 000 cases of fourteen different cancers and about 17 000 controls. Data were sug-
gestive of a protective role of vegetable intake on the risk of several common epithelial cancers. OR for the highest compared with the
lowest levels of consumption ranged from 0·2 (larynx, oral cavity and pharynx) to 0·9 (prostate). Inverse associations were found for
both raw and cooked vegetables, although for upper digestive tract cancers the former were somewhat stronger. Similar inverse associ-
ations were found for cruciferous vegetables. Frequent consumption of allium vegetables was also associated with reduced risk of several
cancers. Fruit was a favourable correlate of the risk of several cancers, particularly of the upper digestive tract, with associations generally
weaker than those reported for vegetables. A reduced risk of cancers of the digestive tract and larynx was found for high consumption of
citrus fruit. Suggestive protections against several forms of cancer, mainly digestive tract cancers, were found for high consumption of
apples and tomatoes. High intakes of fibres, flavonoids and proanthocyanidins were inversely related to various forms of cancer. In con-
clusion, data from our series of case–control studies suggested a favourable role of high intakes of fruit and vegetables in the risk of many
common cancers, particularly of the digestive tract. This adds evidence to the indication that aspects of the Mediterranean diet may have a
favourable impact not only on CVD, but also on several common (epithelial) cancers, particularly of the digestive tract.
Key words: Cancer risk: Diet: Fruit: Vegetables
The Mediterranean diet is a collection of eating patterns
with different components, traditionally followed by popu-
lations from countries bordering the Mediterranean Sea, and
is generally characterised by frequent consumption of fruit,
vegetables, complex carbohydrates, pulses and fish; low con-
sumption of meat and cheese; low-to-moderate amount of
wine intake during meals; and use of olive oil for seasoning
(as a major common characteristic). This dietary pattern has
been suggested as a possible explanation for the longevity
of populations from countries in the Mediterranean regions,
and for the relatively low occurrence of CHD in such areas(1,2).
The Mediterranean diet as a whole and some of its aspects
have been inversely related to the risk of cancer(3–8). In particu-
lar, high intakes of fruit and vegetables have been related to a
reduced risk of cancer at several sites, with associations stronger
for cancers of digestive and respiratory tracts and somewhat
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weaker for hormone-related cancers. However, most of the
epidemiological evidence supporting a favourable role of
vegetables and fruit is derived from case–control studies,
whereas evidence from cohort studies is less convincing(9).
In the present review, we discuss and summarise the
main findings on the relationship between vegetable and
fruit consumption and cancer risk from an integrated series
of multi-centric case–control studies conducted in Italy and
Switzerland.
Methods
Since the early 1990s, a series of case–control studies of var-
ious neoplasms were conducted in Italy and Switzerland.
These included 768 cases of oral and pharyngeal cancer(10),
198 cases of nasopharyngeal cancer(11), 304 cases of oesopha-
geal cancer(12), 230 cases of stomach cancer(13), 1953 cases of
colorectal cancer(14), 185 cases of liver cancer(15), 326 cases of
pancreatic cancer(16), 527 cases of laryngeal cancer(17), 2569
cases of breast cancer(18), 454 cases of endometrial
cancer(19), 1031 cases of ovarian cancer(20), 1294 cases of pros-
tate cancer(21) and 767 cases of kidney cancer(22), 190 cases of
non-Hodgkin’s lymphomas(23) (Table 1); and a total of over
17 000 controls. Cases were individuals admitted to major
teaching and general hospitals with incident, histologically
confirmed cancers. Controls were patients with no history
of cancer, admitted to the same hospitals for acute non-
neoplastic condition, unrelated to known risk factors for the
corresponding cancer site or dietary modification. The study
protocols were revised and approved by the ethical commit-
tees of the hospitals involved, according to the regulations at
the time of study conduction. All participants gave informed
consent.
Trained personnel interviewed cases and controls during
their hospital stay using a structured questionnaire, including
information on sociodemographic characteristics, anthropo-
metric measures, lifestyle habits (e.g. tobacco smoking and
alcohol drinking), dietary habits, personal medical history,
family history of cancer, and, for women, menstrual and repro-
ductive factors, use of oral contraceptives and hormone repla-
cement therapy. The usual diet of the subjects 2 years before
diagnosis (or hospital admission, for controls) was investigated
using a reproducible and valid FFQ(24,25), including seventy-
eight food items and beverages. Subjects were asked to indicate
the average weekly frequency of consumption for each dietary
item, and the seasonal consumption for a few vegetables and
fruit, with the corresponding duration.
OR, and the corresponding 95 % CI, for quintiles (computed
among controls) of vegetable or fruit intake were estimated by
multiple logistic regression models. For nasopharyngeal and
liver cancers and non-Hodgkin’s lymphomas, subjects were
grouped according to quartiles of intake. Although models
were derived independently for each cancer site, according
to their potential confounding factors, all of them included
terms for age, sex (when appropriate), study centre or area
of residence, education and energy intake. Models for liver
and breast cancers were also adjusted for alcohol drinking;
models for stomach cancer were adjusted for tobacco
smoking; and models for cancers of oral cavity and pharynx,
nasopharynx, oesophagus, pancreas, larynx and kidney
were adjusted for both alcohol drinking and tobacco smok-
ing. Allowance for BMI or physical activity was performed
for cancers of oral cavity and pharynx, pancreas, kidney and
colorectum. A term for hepatitis was included in the models
for liver cancer (B and/or C viruses) and non-Hodgkin’s
lymphomas (C virus). Concerning female hormone-related
cancers, OR for breast cancer were also adjusted for parity,
Table 1. Data on selected cancers for the highest v. the lowest levels of consumption of cruciferous and
allium vegetables in Italy and Switzerland, 1991–2009
(Odds ratios, and 95 % confidence intervals)
Cruciferous
vegetables ($1 v.
,1 portion/week)
Allium vegetables
Onion ($7 v.
0 portions/week)
Garlic (high v.
no or low use*)
Cancer sites n OR 95 % CI OR 95 % CI OR 95 % CI
Oral cavity and pharynx 768 0·83 0·70, 0·98 0·16 0·06, 0·46 0·61 0·44, 0·85
Nasopharynx 198 – – –
Oesophagus 304 0·72 0·52, 0·99 0·12 0·02, 0·58 0·43 0·28, 0·67
Stomach† 230 0·90 0·61, 1·30 0·59 0·25, 1·41 0·69 0·41, 1·15
Colorectum 1953 0·83 0·74, 0·94 0·44 0·28, 0·67 0·74 0·63, 0·86
Liver 185 0·72 0·47, 1·11 – –
Pancreas 326 0·90 0·63, 1·30 – –
Larynx 527 0·84 0·67, 1·05 0·17 0·05, 0·61 0·56 0·38, 0·82
Breast 2569 0·83 0·74, 0·94 0·75 0·50, 1·12 0·90 0·77, 1·05
Endometrium† 454 0·93 0·68, 1·27 0·40 0·22, 0·72 0·62 0·42, 0·92
Ovary 1031 0·91 0·76, 1·11 0·27 0·08, 0·85 0·78 0·62, 0·98
Prostate 1294 0·87 0·70, 1·09 0·29 0·07, 1·03 0·81 0·64, 1·00
Kidney 767 0·68 0·54, 0·84 0·62 0·18, 2·10 0·69 0·53, 0·92
Non-Hodgkin’s lymphomas 190 – – –
* Qualitative variable scored as 1 for ‘non-use or low use’, 2 for ‘intermediate use’, and 3 for ‘high use’.
† For endometrial and stomach cancer only, the OR is for consuming $2 v. 0 portions/week of onion.
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those for ovarian cancer were adjusted for parity and oral contra-
ceptive use, and those for endometrial cancer were adjusted for
parity, oral contraceptive use, hormone replacement therapy,
age at menarche, menopausal status and history of diabetes.
In the present review, we also provided results on selected
vegetables or fruit of specific interest, i.e. those that are cheap
and easy to store and transport, and thus the most frequently
consumed.
Vegetables
The present data supported a protective role of high intake
of vegetables in the risk of several common epithelial cancers
(Fig. 1). In particular, the OR for the highest compared with
the lowest levels of vegetable intake were 0·19 (95 % CI
0·13, 0·29) for oral and pharyngeal cancer, 0·51 (95 % CI
0·29, 0·90) for nasopharyngeal cancer, 0·32 (95 % CI 0·19,
0·55) for oesophageal cancer, 0·47 (95 % CI 0·27, 0·81) for
stomach cancer, 0·57 (95 % CI 0·47, 0·69) for colorectal
cancer, 0·72 (95 % CI 0·31, 1·64) for liver cancer, 0·66 (95 %
CI 0·39, 1·12) for pancreatic cancer and 0·17 (95 % CI 0·11,
0·27) for laryngeal cancer. Among hormone-related cancers,
breast, endometrial and ovarian cancers were inversely related
to vegetable consumption, with OR of 0·73 (95 % CI 0·60,
0·88), 0·59 (95 % CI 0·37, 0·94) and 0·47 (95 % CI 0·34, 0·64),
respectively, whereas the estimate for prostate cancer was
below unity (i.e. 0·87), but not significant. A favourable role
of vegetable intake was also observed for kidney cancer
(OR 0·65, 95 % CI 0·47, 0·90), as well as for non-Hodgkin’s
lymphomas (OR 0·49, 95 % CI 0·28, 0·87).
Cooking food may destroy selected nutrients and enzymes,
alter the structure and thus digestibility of the food, and create
by-products. However, for some foods and food components
(e.g. lycopene), cooking not only kills potentially harmful
organisms, but also actually improves the bioavailability
of certain nutrients and digestibility. Findings from our
case–control studies supported inverse relationships between
consumption of both raw and cooked vegetables and the risk
of cancers, with the exception of breast cancer, for which an
inverse association was found essentially for raw vegetables.
In general, these relationships appeared somewhat stronger
for raw than cooked vegetables for upper digestive tract
cancers. OR for the highest v. the lowest intakes (generally
quintiles) of raw and cooked vegetables were respectively,
0·25 and 0·50 for oral and pharyngeal cancer(10), 0·54 and
0·67 for nasopharyngeal cancer(11), 0·32 and 0·79 for oesopha-
geal cancer(12), 0·59 and 0·57 for colorectal cancer(14), 0·77 and
0·57 for pancreatic cancer(16), 0·22 and 0·32 for laryngeal
cancer(17), 0·73 and 0·96 for breast cancer(18), 0·47 and 0·65
for ovarian cancer(20), 0·87 and 0·74 for prostate cancer(21),
and 0·74 and 0·68 for kidney cancer(22).
Cruciferous vegetables (cabbages, cauliflowers, broccoli,
brussels sprouts and turnip greens) are important sources
of sulphur-containing compounds (glucosinolates), whose
major breakdown products (isothiocyanates and indoles)
have anti-carcinogenic properties in in vitro and animal
studies(26). Our data showed significantly reduced OR for
regular ($1 portion/week) compared with no/occasional
intake for cancers of the oral cavity and pharynx, oesophagus,
colorectum, breast and kidney (Table 1)(26).
Frequent consumption of allium vegetables, particularly
onion, represents a peculiar feature of the Mediterranean
diet. Garlic and onion are a source of several organosulphur
compounds in addition to amino acids, vitamins and micro-
nutrients, and have anti-inflammatory, anti-thrombotic,
0·0
Oral cavity and pharynx
Nasopharynx
Oesophagus*
Stomach
Colorectum
Liver
Pancreas
Larynx
Breast*
Endometrium
Ovary*
Prostate*
Kidney
Non-Hodgkin’s lymphomas
0·5 1·0 1·5 2·0
Fig. 1. OR and 95 % CI of selected cancers for the highest quintile v. the
lowest quintile of vegetable consumption for all cancer sites, except for
nasopharyngeal and liver cancers, and non-Hodgkin’s lymphomas (quartiles).
Italy and Switzerland, 1991–2009. *Raw vegetables.
0·0
Oral cavity and pharynx
Nasopharynx
Oesophagus*
Stomach
Colorectum*
Liver
Pancreas
Larynx
Breast*
Endometrium
Ovary*
Prostate*
Kidney
Non-Hodgkin’s lymphomas
0·5 1·0 1·5 2·0
Fig. 2. OR and 95 % CI of selected cancers for the highest quintile v. the
lowest quintile of fruit consumption for all cancer sites, except for nasophar-
yngeal and liver cancers, and non-Hodgkin’s lymphomas (quartiles). Italy and
Switzerland, 1991–2009. *Non-citrus fruits.
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cholesterol-lowering and antioxidant effects(27,28). Data from
the present series of case–control studies support a favourable
role of allium vegetable intake in cancer risk in Italy and
Switzerland (Table 1). In particular, a significantly decreased
risk for high intakes of onion and garlic was found for cancers
of oral cavity and pharynx, oesophagus, colorectum, larynx,
endometrium, ovary and kidney (only garlic)(27–29).
Fruit
Fruit was a favourable correlate of the risk of several cancers,
particularly of the digestive tract; however, associations were
generally weaker than for vegetables. The OR for the highest
compared with the lowest levels of intake were 0·39 (95 % CI
0·26, 0·59) for oral and pharyngeal cancer, 0·52 (95 % CI 0·31,
0·87) for oesophageal cancer, 0·53 (95 % CI 0·30, 0·93) for
stomach cancer, 0·72 (95 % CI 0·60, 0·87) for colorectal
cancer, 0·60 (95 % CI 0·39, 0·98) for pancreatic cancer and
0·52 (95 % CI 0·35, 0·77) for laryngeal cancer (Fig. 2). A
strong association with fruit was also found for non-Hodgkin’s
lymphomas (OR 0·51, 95 % CI 0·30, 0·85). The OR for liver
cancer was around 0·5; however, it did not reach statistical
significance. No appreciable association was observed for
hormone-related and kidney cancers, with OR ranging from
0·83 (endometrial cancer) to 1·02 (kidney cancer).
A reduced risk of cancers of the digestive tract and
larynx was observed in our data for increasing intakes of
citrus fruit, rich in vitamin C, flavanones and other compounds
with antioxidant, anti-mutagenic and anti-proliferative proper-
ties(30). Compared with subjects consuming less than 1 portion
of citrus fruit per week, the OR for those consuming 4 or
more portions per week were 0·47 (95 % CI 0·36, 0·61) for
oral cavity and pharyngeal cancer, 0·42 (95 % CI 0·25, 0·70)
for oesophageal cancer, 0·69 (95 % CI 0·52, 0·92) for stomach
cancer, 0·82 (95 % CI 0·72, 0·93) for colorectal cancer and
0·55 (95 % CI 0·37, 0·83) for laryngeal cancer. For other neo-
plasms, including cancers of breast, ovary, endometrium,
prostate and kidney, no evidence of a beneficial effect of
citrus fruit was found(30).
Apples contain several phytochemicals, including flavo-
noids and phenolic acids, and, when compared with other
fruits, they had the second highest level of antioxidant activity
(after cranberries) and phenolic compounds, and the highest
level of free phenolic compounds(31). Subjects eating at least
one apple a day had a reduced risk of cancers of oral cavity
and pharynx (OR 0·79, 95 % CI 0·62, 1·00), colorectum (OR
0·80, 95 % CI 0·71, 0·90), larynx (OR 0·58, 95 % CI 0·44,
0·76), breast (OR 0·82, 95 % CI 0·73, 0·92) and ovary (OR
0·85, 95 % CI 0·72, 1·00). OR for oesophageal and prostate can-
cers were 0·75 (95 % CI 0·54, 1·03) and 0·91 (95 % CI 0·77,
1·07), respectively (Fig. 3)(31).
Tomatoes are a typical aspect of the Italian diet and, in gen-
eral, of the Mediterranean diet, and are the main source of
lycopene, a carotenoid with strong antioxidant properties
that is not converted to vitamin A(32). Compared with the
lowest quintile of tomato intake, the OR of colorectal cancer
for the highest quintile was 0·8 (95 % CI 0·6, 0·9)(32). We esti-
mated an OR of 0·65 (95 % CI 0·4, 1·0) for cancer of oral
cavity, pharynx and oesophagus, and one of 0·43 (95 % CI
0·3, 0·6) for cancer of the stomach, for the highest compared
with the lowest quartile of intake(33).
Fibres, flavonoids and proanthocyanidins
With regard to specific components of vegetables and fruit,
dietary fibre intake was inversely associated with most cancers
considered, particularly with those of the digestive tract (Fig. 4).
The OR for an increment of intake equal to the difference
between the 80th and 20th percentile were 0·51 (95 % CI 0·40,
0·0
Oral cavity and pharynx
Oesophagus
Colorectum
Larynx
Breast
Ovary
Prostate
0·5 1·0 1·5 2·0
Fig. 3. OR and 95 % CI of selected cancers for consumption of $1 v. ,1
apple/d. Italy, 1991–2002.
0.0
Oral cavity and pharynx
Nasopharynx
Oesophagus
Stomach
Colorectum
Pancreas
Larynx
Breast
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Prostate
Kidney
0·5 1·0 1·5 2·0
Fig. 4. OR and 95 % CI of selected cancers for fibre consumption. Italy and
Switzerland, 1991–2009. Comparisons: difference between 80th and 20th
percentile of the control distribution for oral and pharyngeal, oesophageal
and colorectal cancer; 4th v. 1st quartile of consumption for nasopharyngeal
cancer; 5th v. 1st quintile of consumption for other cancer sites.
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0·66) for oral and pharyngeal cancer, 0·70 (95 % CI 0·51, 0·96) for
oesophageal cancer and 0·68 (95 % CI 0·60, 0·78) for colorectal
cancer. The OR for the highest v. the lowest categories of intake
were 0·58 (95 % CI 0·34, 0·96) for nasopharyngeal cancer, 0·47
(95 % CI 0·28, 0·79) for stomach cancer, 0·4 (95 % CI 0·2, 0·7)
for pancreatic cancer, 0·3 (95 % CI 0·2, 0·4) for laryngeal
cancer and 0·68 (95 % CI 0·53, 0·88) for ovarian cancer. Conver-
sely, a lack of association was observed for cancers of breast,
endometrium, prostate and kidney(34–44).
Results on flavonoids from the present series of Italian and
Swiss case–control studies showed a significant protective
role of flavanones on upper aero-digestive tract cancers
(OR for the highest v. the lowest quintiles of intake 0·51, 95% CI
0·37, 0·71 for oral cavity and pharyngeal cancer; 0·38, 95 %
CI 0·23, 0·66 for oesophageal cancer; 0·60, 95 % CI 0·41, 0·89
for laryngeal cancer), flavonols (OR 0·64, 95 % CI 0·54, 0·77)
and anthocyanidins (OR 0·67, 95 % CI 0·54, 0·82) on colorectal
cancer, flavonols (OR 0·80, 95 % CI 0·66, 0·98) and flavones
(OR 0·81, 95 % CI 0·66, 0·98) on breast cancer, and flavonols
(OR 0·63, 95 % CI 0·47, 0·84) and isoflavones (OR 0·51, 95 %
CI 0·37, 0·69) on ovarian cancer(45,46). Specific results on
proanthocyanidins are shown in Fig. 5. Significant inverse
associations were found for cancers of the stomach,
colorectum, pancreas, endometrium and prostate, with OR
for an increment of intake equal to the difference between
the 20th and the 80th percentile of 0·58 (95 % CI 0·44, 0·77)
for stomach cancer(47), 0·88 (95 % CI 0·81, 0·95) for colorectal
cancer(48), 0·62 (95 % CI 0·49, 0·79) for pancreatic cancer(49),
0·81 for endometrial cancer (95 % CI 0·66, 0·98)(50) and 0·87
(95 % CI 0·76, 0·99) for prostate cancer (unpublished results).
Discussion
Data from this integrated network of studies support a favour-
able role of vegetable intake on the risk of several common
cancers, particularly of the digestive tract. Fruit intake was
inversely related to the risk of digestive tract cancers as well,
with associations generally less stronger than those for vege-
table intake.
Potential limitations include selection and information bias.
However, participation of cases and controls was high and
similar, and attention was paid in excluding from the control
group subjects who were admitted for any condition that
might have affected dietary habits. Furthermore, cases and
controls came from comparable catchment areas and were
interviewed by the same trained personnel in a hospital
setting(51). Among the strengths are the large sample size,
the use of a reproducible and valid FFQ(24,25), and the ability
to adjust for a number of potential confounding factors for the
cancers investigated, as well as energy intake.
In terms of population-attributable risks, 20–60 % of
digestive tract cancers in Italy could be attributable to low con-
sumption of vegetables and fruit. In particular, the risks
attributable to low consumption of vegetables and fruit in
men and women were 25 and 17 % for oral and pharyngeal
cancer, 40 and 29 % for oesophageal cancer, and 18 and
15 % for laryngeal cancer, respectively(52). In both sexes com-
bined, the attributable risks were 60 % for stomach cancer and
43 % for colorectal cancer. For breast cancer, the attributable
risk was 21 %(52).
The favourable effect of vegetables and fruit against
most forms of cancers has been related to several of their
constituents, in the absence, however, of a clear understand-
ing on which of these may be the key relevant ones.
Indeed, vegetables and fruit are sources of a wide variety of
micronutrients and other bioactive compounds, including
carotenoids, folate, vitamins C, D and E as well as vitamin
B6, flavonoids, dietary fibre and selenium. These may act
against cancer through their antioxidant activities, free rad-
ical-trapping capacity, modulation of detoxification enzymes,
anti-mutagenic and anti-proliferative properties, stimulation
of the immune system, as well as modulation of hormone
concentration and hormone metabolism(53). Ascorbic acid,
carotenoids and other antioxidant vitamins were inversely
related to upper digestive and respiratory tract neoplasms(9,54).
Likewise, lycopene was inversely related to several digestive
tract neoplasms, and carotenoids, vitamin E and calcium
showed an inverse relationship with breast cancer(9,54).
However, despite the promising results of several dietary
vitamins and food components on cancer risk from epidemio-
logical studies, trials usually failed to show a protective effect
of vitamin supplementation on cancer risk(55).
Interestingly, a varied diet including several different types
of fruit and vegetables was protective against several cancers
in our data(56–60). Different fruits and vegetables contain
many different bioactive compounds, and these may exert
synergistic interaction. It is, therefore, possible that a combi-
nation of plant-based bioactive components has a favourable
role in cancer risk.
Given the high correlation between several micronutrients,
it is difficult to disentangle their role and detect which specific
component or group of components is responsible for a
protective role against cancer. Since several antioxidants
may influence cancer risk and act to prevent carcinogenesis,
examining overall antioxidant exposure rather than indi-
vidual antioxidants has recently been proposed. Inverse
relationships of the Non-Enzymatic Antioxidant Capacity
0·0
Stomach
Pancreas
Colorectum
Endometrium*
Breast
Ovary
Prostate*
Kidney
0·5 1·0 1·5 2·0
Fig. 5. OR for an increment of proanthocyanidins with $3 mers intake equal
to the difference between the 80th and 20th percentile. Italy and Switzerland,
1991–2009.*Monomers and dimers.
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(NEAC) from diet, measured in terms of ferric reducing–
antioxidant power (FRAP), Trolox equivalent antioxidant
capacity (TEAC) and total radical-trapping antioxidant
parameter (TRAP), were reported in our studies for colorectal
and stomach cancer(61). The OR of colorectal cancer for the
highest v. the lowest quintiles were 0·68 (95 % CI 0·57, 0·82)
for FRAP, 0·69 (95 % CI 0·57, 0·83) for TEAC and 0·69 (95 %
CI 0·57, 0·83) for TRAP(61). The corresponding OR for stomach
cancer were 0·54 (95 % CI 0·33, 0·88) for FRAP, 0·67 (95 % CI
0·42, 1·07) for TEAC and 0·57 (95 % CI 0·39, 0·90) for TRAP,
respectively (submitted).
The beneficial effect of high intakes of vegetables and fruit
in these studies may be also due, at least in part, to the fact
that their high consumption often accompanies lower intakes
of foods that may be positively related to the risk of cancer.
They may, therefore, represent a general indicator of healthy
dietary and lifestyle habits. Indeed, high intakes of fruit and
vegetables are key features of the Mediterranean diet(62),
which has been inversely related to overall mortality as well
as to specific health outcomes including CVD and cerebro-
vascular diseases, as well as cancer(1,2,6,8).
A beneficial role of vegetable and fruit consumption in
the risk of cancer has been reported either from a number
of case–control studies(63–65) or from some large cohort
investigations(66–72). However, also a number of prospective
studies, which generally have a higher level of evidence
than case–control studies, have reported null associations,
casting some doubts about the possible benefits of high
vegetable and fruit consumption(73–77). Findings from the
European Prospective Investigation into Cancer and Nutrition
(EPIC) study, across ten countries, have supported significant
inverse associations between fruit consumption and upper
aero-digestive tract cancers (mouth, pharynx, larynx and oeso-
phagus) and lung cancer (in smokers), as well as between
fruit and vegetable consumptions and colorectal cancer. For
the other cancer sites considered (i.e. stomach, pancreas,
breast, cervix, prostate, bladder and lymphoma), no significant
association was reported for both fruit and vegetables con-
sumption(78). The combined analysis of two major US cohorts,
the Nurses’ Health Study and the Health Professionals’
Follow-up Study (HPFS), indicated no relevant role of fruit
and vegetable intake on overall cancer incidence(75) as well
as on colon and rectal cancer(76), but suggested possible
inverse associations with kidney cancer(71), premenopausal
breast cancer(79) and lung cancer in women but not in
men(80). Prospective data from the Netherlands Cohort Study
on Diet and Cancer have shown a favourable role of vegetable
and fruit intake in colorectal(81) and lung cancers(82), and no
significant association with pancreatic(77), ovarian(83), kidney(84)
and breast cancers(85). Moreover, high intake of fruit, but not
vegetables, reduced urothelial cancer risk(86), and intakes of
specific groups of vegetables (e.g. raw vegetables) and fruits
(e.g. citrus fruits) were inversely related to subtypes of
oesophageal and stomach cancers(87). The Pooling Project
of prospective Studies of Diet and Cancer, an international
consortium of prospective cohort studies(88), found no associ-
ation between fruit and vegetable consumption and the
risk of breast cancer overall (but an inverse association for
oestrogen receptor-negative breast tumours; twenty cohorts/
24 690 cases)(89), pancreatic cancer (fourteen cohorts/
2212 cases)(90), colon cancer overall (but an inverse associ-
ation for distal colon cancer; fourteen cohorts/5838 cases)(91)
and ovarian cancer (twelve cohorts/2130 cases)(92); a modest
inverse association with lung cancer (eight cohorts/3206
cases)(93); and a significant inverse association with kidney
cancer (thirteen cohorts/1474 cases)(94).
In conclusion, our findings, as well as those from other
studies conducted in Mediterranean countries(95,96), indicate
a large favourable effect of vegetable and fruit intake on
the risk of several cancer sites, and this may well be due
to the relative abundance of vegetables and fruit in the
Mediterranean diet.
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